Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott Steps Up Effort To Abandon Alere Deal

Executive Summary

Abbott has asked a Delaware court to cancel its agreement to buy Alere for $5.8bn based on a series of financial and regulatory missteps by Alere. Alere, which earlier sued to force the merger to go through, plans to fight the suit.

Advertisement

Related Content

M&A Analysis: April Showers Big Name Acquisitions
Despite Legal Dispute, Abbott Set To Buy Alere for $5.3bn
Earnings Winners and Losers: BSX, EW, ABT, JNJ, SYK, ZBH
To Alinity And Beyond: Abbott Dx Launches Into Its Next Phase
EU Approves Troubled Abbott-Alere Deal – But Abbott Still Wants Out
Diagnostics In 2016: From Alere To Zika
MTI 100: Medtech Giants Trade Places
M&A Analysis: Underwhelming 2016, But Hope For 2017 US Market Boom
Alere Challenges Medicare Billing Block
January Court Date Set for Abbott, Alere Merger

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT104184

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel